Interactions of 2-, 3- and 4-formyl phenylboronic acids (FPBAs) with sugars, amino sugars, aminoglycosides and various poly- and monoamines have been studied by UV-vis, (1)H and (11)B NMR titrations in water at variable pH. Behavior of 2-FPBA was anomalous in several aspects. Transformation of the acid into its conjugate base was slow in NMR time scale and was accompanied by intramolecular cyclization affording the respective benzoboroxole. The equilibrium constants for imine formation (K(imine)) between 2-FPBA and simple monoamines including amino sugars were ca. 2 orders of magnitude larger than those with other isomers. Still one order of magnitude larger K(imine) values were observed for 2-FPBA with aminoglycosides (kanamycin, amikacin, gentamicin, neomycin) and polyamines (spermine, spermidine). The examination of UV-vis and (11)B NMR spectra of imines formed with 2-FPBA showed that formally neutral Schiff bases in fact were zwitterionic species containing a protonated imine group and an anionic B(OH)(3)(-) group. The enhanced stability of imines with monoamines can therefore be attributed to the electrostatic stabilization provided by the zwitterionic structure and further increased stability of imines with antibiotics and polyamines is explicable by additional stabilization of the borate anionic group by ion paring with ammonium groups not involved in Schiff base formation. Thanks to high molar absorptivity of protonated imines interaction of 2-FPBA with aminoglycosides allows detecting them spectrophotometrically in a μM concentration range in neutral aqueous solutions in the presence of sugars, amino sugars and amino acids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.